RxDoctor Payments DataLook up a doctor →

Peter Bergsagel, MD

Hematology & Oncology · Scottsdale, AZNPI 1316920150

Payments from drug & device makers

$3,574,959in general payments, 2019–2025

Across 100 payments — averaging $35,750 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bristol Myers Squibb$3M
  • Sanofi US Services Inc.$447K
  • E.r. Squibb & Sons, L.L.C.$83K
  • Novartis$52K
  • Pfizer$5K
  • AbbVie$5K
  • plus $8K from 6 others

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,574,959 in reported general payments places this provider in the 90th percentile of 261 hematology & oncology providers in Arizona.

See all hematology & oncology providers in Arizona

Medicare billing

Part B allowed, 2024
$2,286,204
Medicare patients
500
Services billed
76,143

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →